当前位置：药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 上市日期： -格式:2020-5-3
注册申请号： 市场分类： 活性成分： 持证企业：
 美国NDC未完成药物数据库文件21130条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
Raloxifene hydrochloride
DRUG FOR FURTHER PROCESSING
0110-4184
Lilly del Caribe, Inc.
19980106
RALOXIFENE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
60
0110-4184_4b94e4b0-f381-4cf8-900d-35c46793f481
lasmiditan
DRUG FOR FURTHER PROCESSING
0110-4312
Lilly del Caribe, Inc.
20191011
LASMIDITAN
DRUG FOR FURTHER PROCESSING
50
0110-4312_dd9bd2c1-2d31-40e8-a835-4f14607afd78
Tadalafil
DRUG FOR FURTHER PROCESSING
0110-4462
Lilly del Caribe, Inc.
20031126
TADALAFIL
DRUG FOR FURTHER PROCESSING
5
0110-4462_668755cf-c65c-4ec5-8e64-ab2902d1b0f2
Tadalafil
DRUG FOR FURTHER PROCESSING
0110-4463
Lilly del Caribe, Inc.
20031126
TADALAFIL
DRUG FOR FURTHER PROCESSING
10
0110-4463_668755cf-c65c-4ec5-8e64-ab2902d1b0f2
Tadalafil
DRUG FOR FURTHER PROCESSING
0110-4464
Lilly del Caribe, Inc.
20031126
TADALAFIL
DRUG FOR FURTHER PROCESSING
20
0110-4464_668755cf-c65c-4ec5-8e64-ab2902d1b0f2
Tadalafil
DRUG FOR FURTHER PROCESSING
0110-4465
Lilly del Caribe, Inc.
20080107
TADALAFIL
DRUG FOR FURTHER PROCESSING
2.5
0110-4465_668755cf-c65c-4ec5-8e64-ab2902d1b0f2
Tadalafil
DRUG FOR FURTHER PROCESSING
0110-4467
Lilly del Caribe, Inc.
20090522
TADALAFIL
DRUG FOR FURTHER PROCESSING
20
0110-4467_668755cf-c65c-4ec5-8e64-ab2902d1b0f2
baricitinib
DRUG FOR FURTHER PROCESSING
0110-4479
Lilly del Caribe, Inc.
20170116
BARICITINIB
DRUG FOR FURTHER PROCESSING
4
0110-4479_8564dd56-b161-4792-b9b0-95aefbab9742
abemaciclib
DRUG FOR FURTHER PROCESSING
0110-4483
Lilly del Caribe, Inc.
20170928
ABEMACICLIB
DRUG FOR FURTHER PROCESSING
50
0110-4483_efa0ca21-de50-4c40-a66b-23135b588cd2
lasmiditan
DRUG FOR FURTHER PROCESSING
0110-4491
Lilly del Caribe, Inc.
20191011
LASMIDITAN
DRUG FOR FURTHER PROCESSING
100
0110-4491_dd9bd2c1-2d31-40e8-a835-4f14607afd78
orforglipron
DRUG FOR FURTHER PROCESSING
0110-4503
Lilly del Caribe, Inc.
20250930
ORFORGLIPRON CALCIUM
DRUG FOR FURTHER PROCESSING
2.5
0110-4503_f2d80f03-bd49-4c2c-8064-9044d0c75dd0
baricitinib
DRUG FOR FURTHER PROCESSING
0110-4732
Lilly del Caribe, Inc.
20190110
BARICITINIB
DRUG FOR FURTHER PROCESSING
1
0110-4732_8564dd56-b161-4792-b9b0-95aefbab9742
orforglipron
DRUG FOR FURTHER PROCESSING
0110-4794
Lilly del Caribe, Inc.
20251004
ORFORGLIPRON CALCIUM
DRUG FOR FURTHER PROCESSING
5.5
0110-4794_f2d80f03-bd49-4c2c-8064-9044d0c75dd0
orforglipron
DRUG FOR FURTHER PROCESSING
0110-4803
Lilly del Caribe, Inc.
20251017
ORFORGLIPRON CALCIUM
DRUG FOR FURTHER PROCESSING
9
0110-4803_f2d80f03-bd49-4c2c-8064-9044d0c75dd0
abemaciclib
DRUG FOR FURTHER PROCESSING
0110-4815
Lilly del Caribe, Inc.
20170928
ABEMACICLIB
DRUG FOR FURTHER PROCESSING
100
0110-4815_efa0ca21-de50-4c40-a66b-23135b588cd2
orforglipron
DRUG FOR FURTHER PROCESSING
0110-4839
Lilly del Caribe, Inc.
20251015
ORFORGLIPRON CALCIUM
DRUG FOR FURTHER PROCESSING
14.5
0110-4839_f2d80f03-bd49-4c2c-8064-9044d0c75dd0
orforglipron
DRUG FOR FURTHER PROCESSING
0110-4953
Lilly del Caribe, Inc.
20251005
ORFORGLIPRON CALCIUM
DRUG FOR FURTHER PROCESSING
17.2
0110-4953_f2d80f03-bd49-4c2c-8064-9044d0c75dd0
abemaciclib
DRUG FOR FURTHER PROCESSING
0110-5337
Lilly del Caribe, Inc.
20170928
ABEMACICLIB
DRUG FOR FURTHER PROCESSING
150
0110-5337_efa0ca21-de50-4c40-a66b-23135b588cd2
abemaciclib
DRUG FOR FURTHER PROCESSING
0110-6216
Lilly del Caribe, Inc.
20170928
ABEMACICLIB
DRUG FOR FURTHER PROCESSING
200
0110-6216_efa0ca21-de50-4c40-a66b-23135b588cd2
Duloxetine hydrochloride
DRUG FOR FURTHER PROCESSING
0110-9542
Lilly del Caribe, Inc.
20041217
DULOXETINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
60
0110-9542_a2802fac-1267-445b-8e16-3a4204b8acec
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3